Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-19 09:00 am Sale | 13D | Revance Therapeutics Inc. RVNC | Teoxane SA | 0 0.000% | -6,550,800 (Position Closed) | View |
| 2023-10-24 4:05 pm Purchase | 13D | Revance Therapeutics Inc. RVNC | Teoxane SA | 6,550,800 7.400% | 2,105,000 (+47.35%) | View |
| 2023-09-01 09:12 am Purchase | 13D | Revance Therapeutics Inc. RVNC | Teoxane SA | 4,445,800 5.000% | 4,445,800 (New Position) | View |